Cargando…
肺癌合并间质性肺炎药物治疗研究进展
Interstitial lung disease (ILD) is a risk factor for lung cancer. Patients with lung cancer associated with ILD (LC-ILD) often appear clinically. During the treatment of LC-ILD, there is a risk of causing acute exacerbation or even death in the treatment of lung cancer. At the same time, combining I...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210086/ https://www.ncbi.nlm.nih.gov/pubmed/32316717 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.01 |